Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-018300
Filing Date
2025-06-26
Accepted
2025-06-26 18:21:28
Documents
1
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 form4-06262025_100625.html 4  
1 form4-06262025_100625.xml 4 11325
  Complete submission text file 0001415889-25-018300.txt   13061
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Issuer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CELSUS THERAPEUTICS PLC 24 WEST 40TH STREET NEW YORK NY 10018
Business Address
Shaw Allan (Reporting) CIK: 0001626850 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39538 | Film No.: 251081687